Monoclonal gammopathy of undetermined significance and polyneuropathy

Medicine & Life Sciences

• Monoclonal Gammopathy of Undetermined Significance 100%
• Polyneuropathies 83%
• Immunoglobulin M 62%
• Myelin-Associated Glycoprotein 59%
• Paraproteins 43%
• Paraproteinemias 27%
• Rituximab 19%
• Antibodies 17%
• Myelin Sheath 13%
• Immunoglobulin G 9%
• Neural Conduction 9%
• Immunoglobulin A 8%
• B-Lymphocytes 6%
• JC Virus 6%
• Progressive Multifocal Leukoencephalopathy 6%
• Serum 6%
• Waldenstrom Macroglobulinemia 6%
• Avitaminosis 5%
• Muscle Cramp 5%
• Autonomic Pathways 5%
• Peptides 5%
• Plasma Exchange 5%
• Paresthesia 5%
• Hypesthesia 5%
• Schwann Cells 4%
• Proteins 4%
• Tremor 4%
• Muscle Weakness 4%
• Surface Antigens 4%
• Nucleosides 4%
• Demyelinating Diseases 4%
• Peripheral Nervous System Diseases 4%
• Plasma Cells 4%
• Multiple Myeloma 4%
• Electrophoresis 4%
• Age of Onset 4%
• Causality 4%
• Alcoholism 4%
• Action Potentials 3%
• Blood Proteins 3%
• Axons 3%
• Carbohydrates 3%
• Electron Microscopy 3%
• Foot 3%
• Therapeutics 3%
• Diabetes Mellitus 3%
• Clone Cells 3%
• Hand 3%
• Virus Diseases 3%
• Light 3%
• Randomized Controlled Trials 2%
• Biopsy 2%
• Skin 2%
• Pharmaceutical Preparations 1%
• Population 1%
• Neoplasms 1%